Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Dubai-Based Al-Futtaim Electronic - Techserve Partners with TytoCare to Expand Digital Health Services
TytoCare, the global health care industry’s first all-in-one modular device and examination platform for AI-powered, […]
England to Return to Plan A Following the Success of the Booster Programme
The government has today announced that England will fully return to Plan A on Thursday […]
Nym Health Names Or Peles Senior Vice President of Research & Development
Nym Health, a leader in autonomous medical coding, today announced that Or Peles has joined […]
Regulus Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA for RGLS8429
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines […]
New Breast and Lung Cancer Treatments Approved in Scotland
3 new cancer treatments have now been approved by the Scottish Medicines Consortium (SMC) for […]
EmpiRx Health Appoints Nada Nicholas as Senior Vice President of Business Development for Labor
EmpiRx Health, the industry’s only value-based pharmacy benefit manager (PBM), today announced it has appointed Nada […]
Seekyo Reinforces Scientific Advisory Board with Two New Members
Seekyo, a startup company specializing in developing smart chemotherapy drugs, today announces the appointment of two […]
GPX Embolic Device Success in Challenging Tumor Case
Fluidx Medical‘s GPX Embolic Device was used to effectively devascularize a large tumor with multiple […]
NuvoAir Series A Funding Reaches $25M to Expand Patient-Centric Care and Clinical Trials Platform
NuvoAir, a leading digital healthcare company working in chronic disease management, raised $11M in a […]
Amniotics Secures Funding of SEK 4,8 Million from Vinnova to Develop Stem Cell Therapies
Amniotics AB (publ) (Nasdaq Stockholm: AMNI) today announced that it has received a non-diluting grant […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more